The Core Issue: Failure to Warn Patients of Severe Risks The central argument in the GLP-1 lawsuits is that manufacturers like Novo Nordisk and Eli Lilly knew, or should have known, about the risk of severe side effects like stomach paralysis and bowel obstruction but failed to adequately warn doctors and patients
Taltz's generic name is ixekizumab
A trained professional should give them in a clinic setting
The FDA set transition periods: 503A compounding pharmacies could continue compounding tirzepatide through specified deadlines, and 503B outsourcing facilities had slightly longer windows
Two regulatory bodies are relevant here: The Medicines and Healthcare products Regulatory Agency (MHRA) oversees the regulation of herbal medicines through the Traditional Herbal Registration (THR) scheme
It mentions insulated medicine coolers, cooling sleeves, and compact travel refrigerators as available options, while noting they add cost and complexity